Cambrian BioPharma Inc's Form 4 filing
Faeth Therapeutics, Inc. (FTH) · filed Feb 22, 2022
- Accession no.
- 0001567619-22-005190
- Filed
- Feb 22, 2022
- Trade date
- Feb 17-18, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $80.2K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cambrian BioPharma IncCIK 0001797409 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | Common Stock | PPurchaseAcquired | +4,949 | $4.17 | +$20,637.33 | 5,193,286 | Direct | |
| Feb 18, 2022 | Common Stock | PPurchaseAcquired | +15,000 | $3.97 | +$59,550 | 5,208,286 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.